Home  >  Speakers  >  Jerry Mclaughlin
Jerry  Mclaughlin

Jerry Mclaughlin

President, CEO | Carmel, Indiana    United States Of America
Biotechnology, Clinical Pharmacology,...More
Pharmacy, Medicine,...More
Spoken at 1 event

Biography :

AgeneBio is developing drugs to treat the pre dementia stage of Alzheimers disease, and other neurological and psychiatric conditions. The company announced encouraging mid stage results for its lead therapeutic, which works by quieting hyperactivity in the hippocampus portion of the brain, which plays a critical role in the formation of memory. We spoke to Jerry McLaughlin, CEO of AgeneBio about the company’s efforts, why this approach holds promise in delaying the onset of dementia in Alzheimers patients, and whether this approach may have implications for other neurological and psychiatric.

For speaker's contact information - Contact us


Biotechnology, Clinical Pharmacology, Neuroscience

Interested Topics

Pharmacy, Medicine, Neuroscience, Biotechnology, Psychiatric, Alzheimers, Therapeutics, Neurodegeneration, Preserves, Cognitive function, Annonaceous acetogenins, Pawpaw

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.



Conference Session Materials

The conference session material has yet to be added by the speaker.

Send Message

Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.